Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tobias C Dreher"'
Autor:
Katharina Koepsel, Tobias C. Dreher, Christian Blockhaus, Michael Gotzmann, Norbert Klein, Thomas Kuntz, Dong-In Shin, Hendrik Lapp, Fabian Schiedat, Mohammad Abumayyaleh, Thomas Beiert, Christian Weth, Boldizsar Kovacs, Stephanie Rosenkaimer, Jacqueline Kowitz, Ardan Muammer Saguner, Julia W. Erath, Firat Duru, Andreas Mügge, Ibrahim Akin, Assem Aweimer, Nazha Hamdani, Ibrahim El-Battrawy
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
BackgroundData on the use of the wearable cardioverter defibrillator in patients suffering from inherited and congenital heart disease are limited. Consequently, evidence for guideline recommendations in this patient population is lacking.MethodsIn t
Externí odkaz:
https://doaj.org/article/bb2ce12e356546f6a0175ea462642e7d
Autor:
Ibrahim El‐Battrawy, Katharina Koepsel, David Tenbrink, Boldizsar Kovacs, Tobias C. Dreher, Christian Blockhaus, Michael Gotzmann, Norbert Klein, Thomas Kuntz, Dong‐In Shin, Hendrik Lapp, Stephanie Rosenkaimer, Mohammad Abumayyaleh, Nazha Hamdani, Ardan Muammer Saguner, Jacqueline Kowitz, Julia W. Erath, Firat Duru, Andreas Mügge, Ibrahim Akin, Assem Aweimer, Thomas Beiert
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 18 (2023)
Background Data on the use of the wearable cardioverter‐defibrillator (WCD) among patients with myocarditis remain sparse. Consequently, evidence for guideline recommendations in this patient population is lacking. Methods and Results In total, 159
Externí odkaz:
https://doaj.org/article/c3e740e36dfc421ebaa3be5e8a027544
Autor:
Ibrahim El-Battrawy, Boldizsar Kovacs, Tobias C. Dreher, Norbert Klein, Stephanie Rosenkaimer, Susanne Röger, Jürgen Kuschyk, Ardan Muammer Saguner, Jacqueline Kowitz, Julia W. Erath, Firat Duru, Ibrahim Akin
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Patients at high risk for sudden cardiac death (SCD) may benefit from wearable cardioverter defibrillators (WCD) by avoiding immediate implantable cardioverter defibrillator (ICD) implantation. Different factors play an important role includ
Externí odkaz:
https://doaj.org/article/651b9fc86bcb432887b6a2bbcc0fd914
Autor:
Ibrahim El‐Battrawy, David Tenbrink, Boldizsar Kovacs, Tobias C. Dreher, Christian Blockhaus, Norbert Klein, Dong‐In Shin, Mido Hijazi, Stephanie Rosenkaimer, Thomas Beiert, Mohammad Abumayyaleh, Ardan Muammer Saguner, Jacqueline Kowitz, Julia W. Erath, Firat Duru, Andreas Mügge, Assem Aweimer, Ibrahim Akin
Publikováno v:
European Journal of Clinical Investigation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b453635b2493aa24b62c388e05cdb616
https://doi.org/10.1111/eci.13977
https://doi.org/10.1111/eci.13977
Autor:
Mohammad Abumayyaleh, Tobias C. Dreher, Stephanie Rosenkaimer, Susanne Röger, Julia W. Erath, Norbert Klein, Boldizsar Kovacs, Firat Duru, Ardan M. Saguner, Ibrahim El‐Battrawy, Ibrahim Akin
Treatment with the wearable cardioverter defibrillator (WCD) may protect against sudden cardiac death (SCD) as a bridging therapy until a cardioverter-defibrillator may be implanted. We analyzed in a multicenter setting a consecutive patient cohort w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3605bb074a7577325cb9aa7499024f2e
https://www.zora.uzh.ch/id/eprint/230154/
https://www.zora.uzh.ch/id/eprint/230154/
Autor:
Stephanie Rosenkaimer, Jürgen Kuschyk, Ibrahim Akin, Susanne Röger, Stefan Gerhards, Martin Borggrefe, Ibrahim El-Battrawy, Tobias C Dreher
Publikováno v:
In Vivo
Background/Aim: The wearable cardioverter/defibrillator (WCD) is recommended to prevent sudden cardiac death (SCD). Guidelines suggest a 90 days’ period, but prolongation of WCD wear time until increasing the ejection fraction (≥35%) might be sug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dbd40b1aa27c09b68acca1747223762
https://doi.org/10.21873/invivo.12205
https://doi.org/10.21873/invivo.12205
Autor:
Mohammad Abumayyaleh, Tobias C. Dreher, Ibrahim El-Battrawy, Stephanie Rosenkaimer, Susanne Röger, Julia Erath, Norbert Klein, Boldizsar Kovacs, Firat Duru, Ardan Saguner, Ibrahim Akin
Aims The treatment with the wearable cardioverter defibrillator (WCD) may protect against sudden cardiac death (SCD) as a bridging therapy until a cardioverter-defibrillator may be implanted. We analyzed in a multicenter setting a consecutive patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cfb97df876bda642b2b753d9395149db
https://doi.org/10.22541/au.164244087.73878990/v1
https://doi.org/10.22541/au.164244087.73878990/v1
Autor:
Stephanie L. Rosenkaimer, Ibrahim El-Battrawy, Tobias C. Dreher, Stefan Gerhards, Susanne Röger, Jürgen Kuschyk, Martin Borggrefe, Ibrahim Akin
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 9, Iss 3, p 893 (2020)
Journal of Clinical Medicine, Vol 9, Iss 3, p 893 (2020)
Background: The wearable cardioverter-defibrillator (WCD) is available for patients at high risk for sudden cardiac death (SCD) when immediate implantable cardioverter-defibrillator (ICD) implantation is not possible or indicated. Patient selection r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ea76ed7786590e4b7dd5e22e56ca492b
http://europepmc.org/articles/PMC7141506
http://europepmc.org/articles/PMC7141506